Core Viewpoint - Yifeng Pharmacy's stock price has decreased by 2.20% to 23.96 yuan, with a trading volume of 2.17 billion yuan, indicating market volatility and investor sentiment [1] Company Overview - Yifeng Pharmacy primarily engages in drug retail and health services, covering pharmaceutical commerce and domestic circulation [1] - The company has expanded its store scale through acquisitions, with operations spanning multiple provinces and cities across the country [1] Recent Developments - The controlling shareholder and concerted parties have recently reduced their holdings by 24.248 million shares, accounting for 2% of the total share capital, realizing approximately 555 million yuan [1] - The reduction includes a core employee shareholding platform, resulting in a decrease of their holding ratio to 32.85% [1] - Company executives have also previously engaged in share reductions [1] Financial Performance - In Q1 2025, the company's net profit increased by 10.51% year-on-year, while revenue growth slowed to 0.64%, reflecting a decline compared to previous years [1] Market Activity - On the day of reporting, Yifeng Pharmacy experienced a net inflow of 1.02 million yuan in main funds, but over the past five days, there was a net outflow of 11.8944 million yuan [1]